BioStock: The five best life science stocks of the first half-year

July 5, 2023
Language flag

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.

This great acknowledgment comes from Biostock, Scandinavia’s leading digital news and analysis service for the Life Science sector. PHI’s performance has been recognized alongside the life science companies Prolight Diagnostics, Saniona, Lipidor, and Ziccum.

Our team is honored to feature on this top list. And we remain committed to advancing our innovative solutions for non-invasive cell analysis and quality control in regenerative medicine.

Read the full article on biostock.se.

Latest News

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 December 2024

Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”) will hold an Extraordinary General Meeting on 2 December 2024 at 15.00 CET at the Company’s premises, Skiffervägen 48 in Lund.

PHI resolves on a fully secured rights issue of shares of approximately SEK 64.3 million

The Board of Directors of Phase Holographic Imaging PHI AB has today resolved on a rights issue of shares, with preferential rights for the Company’s existing shareholders, of approximately SEK 64.3 million before deduction of issue related costs, subject to approval by the extraordinary general meeting to be held on 2 December 2024. The purpose of the Rights Issue is to fund a strategic development plan and to strengthen the Company’s capital structure by repayment/off-setting of outstanding loans.

Adopting the final Annual Report

PHI intends to convene a general meeting to adopt the annual report for the fiscal year 2023/2024 and to amend resolutions regarding election of board members and the number of board members.
See All News